The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review

INTRODUCTION: Alcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars. Current treatment options for AUD have moderate therapeutic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldfine, Charlotte E., Tom, Jeremiah J., Im, Dana D., Yudkoff, Benjamin, Anand, Amit, Taylor, Joseph J., Chai, Peter R., Suzuki, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172666/
https://www.ncbi.nlm.nih.gov/pubmed/37181899
http://dx.doi.org/10.3389/fpsyt.2023.1141836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172666/
https://www.ncbi.nlm.nih.gov/pubmed/37181899
http://dx.doi.org/10.3389/fpsyt.2023.1141836

Ejemplares similares